Rebecca L. Harney
Rebecca L. Harney publishes mostly in Oncology, Hematology and Psychiatry and Mental health, on topics such as Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms and Hematopoietic Stem Cell Transplantation.
- World rank
- #6,091,182 of 7,710,434 ranked researchers
- Rank in United States
- #1,474,173 of 1,627,098
- Works
- 15
- Citations
- 117
- Citations per work
- 7.8
What does Rebecca L. Harney research?
Rebecca L. Harney's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (7%), Engineering (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences960.5%
- Medicine960.5%
- Everything else427.8%
- Life Sciences17.0%
- Physical Sciences14.7%
- Engineering14.7%
- 1Oncology30% of their works
- 2Hematology14% of their works
- 3Psychiatry and Mental health12% of their works
- 4Molecular Biology7% of their works
- 5Pharmacology5% of their works
- 6Biomedical Engineering5% of their works
Research topics
- Cancer Treatment and Pharmacology
- Cancer therapeutics and mechanisms
- Hematopoietic Stem Cell Transplantation
- Colorectal Cancer Treatments and Studies
- Microfluidic and Capillary Electrophoresis Applications
- Chronic Myeloid Leukemia Treatments
- HER2/EGFR in Cancer Research
- Schizophrenia research and treatment
Which keywords describe Rebecca L. Harney's research?
The keywords of their largest research topics: Chemotherapy, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Bone Marrow Niche, Cetuximab, DNA, Hematopoietic Stem Cells and KRAS Mutations.
- Neurocognitive Deficits
- Imatinib
- Breast Cancer
- Antipsychotic Drugs
- KRAS Mutations
- DNA
- Bone Marrow Niche
- Chemotherapy-Induced Peripheral Neuropathy
- Chemotherapy
- Taxanes
- Cetuximab
- Hematopoietic Stem Cells
- Topoisomerases
- BCR-ABL
- HER2
- Lab-on-a-Chip
- Poly(dimethylsiloxane)
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Chemotherapy83 topics
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Taxanes61 topic
- Bone Marrow Niche31 topic
- Cetuximab31 topic
- DNA31 topic
- Hematopoietic Stem Cells31 topic
- KRAS Mutations31 topic
- Topoisomerases31 topic
- Antipsychotic Drugs21 topic
- BCR-ABL21 topic
- Breast Cancer21 topic
- HER221 topic
- Imatinib21 topic
- Lab-on-a-Chip21 topic
- Neurocognitive Deficits21 topic
- Poly(dimethylsiloxane)21 topic
Where does Rebecca L. Harney work?
Rebecca L. Harney's main affiliation in the publication record is Saladax Biomedical (United States), United States.
How many publications and citations does Rebecca L. Harney have?
OpenAlex counts 15 works and 117 citations for Rebecca L. Harney, an h-index of 6, ranking #6,091,182 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rebecca L. Harney. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.